Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore L Drell

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|June 6, 2012
Translational research in oncology: the need of additional in vitro preclinical testing methods for new drugsTheodore L Drell, Kurt S Zanker, Frank Entschladen
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Inhibitors for metastasis developmentKerstin Lang, Theodore L Drell, Kurt S Zaenker, et al.
Medical Hypotheses|March 7, 2006
Neoneurogenesis: tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesisFrank Entschladen, Daniel Palm, Kerstin Lang, et al.
Immunology Letters|December 23, 2003
Neurotransmitters regulate the migration and cytotoxicity in natural killer cellsKerstin Lang, Theodore L Drell, Bernd Niggemann, et al.
Journal of Bioenergetics and Biomembranes|June 1, 2004
Expression, isolation, and crystallization of the catalytic domain of CopB, a putative copper transporting ATPase from the thermoacidophilic archaeon Sulfolobus solfataricusKatrin Deigweiher, Theodore L Drell, Alexander Prutsch, et al.
Current Pharmaceutical Design|February 23, 2005
Neurotransmitters and chemokines regulate tumor cell migration: potential for a new pharmacological approach to inhibit invasion and metastasis developmentFrank Entschladen, Theodore L Drell, Kerstin Lang, et al.
Cancer Immunology, Immunotherapy : CII|October 3, 2002
Neurotransmitters are regulators for the migration of tumor cells and leukocytesFrank Entschladen, Kerstin Lang, Theodore L Drell, et al.
Current Pharmaceutical Design|November 30, 2007
Connecting a tumor to the environmentFrank Entschladen, Daniel Palm, Theodore L Drell, et al.
The Lancet. Oncology|March 31, 2004
Tumour-cell migration, invasion, and metastasis: navigation by neurotransmittersFrank Entschladen, Theodore L Drell, Kerstin Lang, et al.
Current Stem Cell Research & Therapy|January 29, 2008
Stem cell migration: a quintessential stepping stone to successful therapyCorinna Weidt, Bernd Niggemann, Benjamin Kasenda, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|June 6, 2012
Translational research in oncology: the need of additional in vitro preclinical testing methods for new drugsTheodore L Drell, Kurt S Zanker, Frank Entschladen
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Inhibitors for metastasis developmentKerstin Lang, Theodore L Drell, Kurt S Zaenker, et al.
Medical Hypotheses|March 7, 2006
Neoneurogenesis: tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesisFrank Entschladen, Daniel Palm, Kerstin Lang, et al.
Immunology Letters|December 23, 2003
Neurotransmitters regulate the migration and cytotoxicity in natural killer cellsKerstin Lang, Theodore L Drell, Bernd Niggemann, et al.
Journal of Bioenergetics and Biomembranes|June 1, 2004
Expression, isolation, and crystallization of the catalytic domain of CopB, a putative copper transporting ATPase from the thermoacidophilic archaeon Sulfolobus solfataricusKatrin Deigweiher, Theodore L Drell, Alexander Prutsch, et al.
Current Pharmaceutical Design|February 23, 2005
Neurotransmitters and chemokines regulate tumor cell migration: potential for a new pharmacological approach to inhibit invasion and metastasis developmentFrank Entschladen, Theodore L Drell, Kerstin Lang, et al.
Cancer Immunology, Immunotherapy : CII|October 3, 2002
Neurotransmitters are regulators for the migration of tumor cells and leukocytesFrank Entschladen, Kerstin Lang, Theodore L Drell, et al.
Current Pharmaceutical Design|November 30, 2007
Connecting a tumor to the environmentFrank Entschladen, Daniel Palm, Theodore L Drell, et al.
The Lancet. Oncology|March 31, 2004
Tumour-cell migration, invasion, and metastasis: navigation by neurotransmittersFrank Entschladen, Theodore L Drell, Kerstin Lang, et al.
Current Stem Cell Research & Therapy|January 29, 2008
Stem cell migration: a quintessential stepping stone to successful therapyCorinna Weidt, Bernd Niggemann, Benjamin Kasenda, et al.
Pageof 2